Abiopharma

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO® (copper histidinate), the First and Only Approved Treatment for Menkes Disease in the United States

(99% Neutral) Amneal Pharmaceuticals Inc. (AMRX) Reports Q1 2026 Financial Results

/C O R R E C T I O N -- Armata Pharmaceuticals, Inc./

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated <em>Staphylococcus aureus</em> Bacteremia

BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS™ Patient

XTL Biopharmaceuticals Acquires 85% of Beyond Airs Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease

Anavex Joins ACCESS-AD, Major Initiative Funded by the EU Commission, through Clinical Evaluation of Blarcamesine as Part of Precision Medicine in AD

Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

(90% Positive) Armata Pharmaceuticals Inc. (ARMP) Announces Enrollment Update for initiate Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(30% Negative) Sono-Tek Corp (SOTK) Reports Q1 2026 Financial Results

(70% Positive) Sight Sciences Inc (SGHT) Reports Q1 2026 Financial Results

(90% Positive) Kymera Therapeutics Inc (KYMR) Announces Enrollment Update for medicines Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment